Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

181

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N06AX11	REMERON SOLTAB	B	Mirtazapine - 30mg	30mg	Tablet, orodispersible	1,486,290 L.L
N05AH03	PRANZA	G	Olanzapine - 5mg	5mg	Tablet, orodispersible	1,773,872 L.L
N05AH03	ZOLAPINE	G	Olanzapine - 5mg	5mg	Tablet, orodispersible	1,186,165 L.L
N05AH03	ZYRWAN OD	G	Olanzapine - 5mg	5mg	Tablet, orodispersible	831,391 L.L
N05AH03	PRANZA	G	Olanzapine - 10mg	10mg	Tablet, orodispersible	3,553,120 L.L
N05AH03	ZOLAPINE	G	Olanzapine - 10mg	10mg	Tablet, orodispersible	2,106,249 L.L
N05AH03	ZYRWAN OD	G	Olanzapine - 10mg	10mg	Tablet, orodispersible	2,564,819 L.L
A03FA03	MOTIDOL ODT	G	Domperidone - 10mg	10mg	Tablet, orodispersible	259,810 L.L
N06DA02	DONEPEZIL/ GENEPHARM	G	Donepezil - 10mg	10mg	Tablet, orodispersible	1,779,247 L.L
N06DA02	YASNAL Q-TAB	G	Donepezil - 10mg	10mg	Tablet, orodispersible	1,376,095 L.L
N06DA02	DONEPEZIL/ GENEPHARM	G	Donepezil - 5mg	5mg	Tablet, orodispersible	1,634,112 L.L
N06DA02	YASNAL Q-TAB	G	Donepezil - 5mg	5mg	Tablet, orodispersible	1,376,095 L.L
A04AA01	ONDANSETRON ARROW	G	Ondansetron - 8mg	8mg	Tablet, orodispersible	1,280,682 L.L
A04AA01	ONZETRAN OD	G	Ondansetron - 8mg	8mg	Tablet, orodispersible	1,023,880 L.L
A04AA01	ZONETRON ODT	G	Ondansetron - 8mg	8mg	Tablet, orodispersible	998,283 L.L
A04AA01	ZONETRON ODT	G	Ondansetron - 4mg	4mg	Tablet, orodispersible	972,686 L.L
N02CC03	ZOLMITRIPTAN BIOGARAN	G	Zolmitriptan - 2.5mg	2.5mg	Tablet, orodispersible	921,876 L.L
N02CC03	ZOLMITRIPTAN BIOGARAN	G	Zolmitriptan - 2.5mg	2.5mg	Tablet, orodispersible	1,683,835 L.L
N05AX12	ZALONIL	G	Aripiprazole - 10mg	10mg	Tablet, orodispersible	1,988,887 L.L
N05AX12	ZALONIL	G	Aripiprazole - 15mg	15mg	Tablet, orodispersible	2,426,980 L.L
N03AF01	NEUROTOP RETARD	G	Carbamazepine - 600mg	600mg	Tablet, prolonged release	1,569,608 L.L
N03AF01	NEUROTOP RETARD	G	Carbamazepine - 300mg	300mg	Tablet, prolonged release	931,283 L.L
N03AG01	CONVULEX RETARD	G	Sodium Valproate - 500mg	500mg	Tablet, prolonged release	423,310 L.L
C03BA11	ADEX	G	Indapamide - 1.5mg	1.5mg	Tablet, prolonged release	296,989 L.L
C03BA11	RAWEL SR	G	Indapamide - 1.5mg	1.5mg	Tablet, prolonged release	362,837 L.L
M01AB05	OLFEN-75 SR	G	Diclofenac sodium - 75mg	75mg	Tablet, prolonged release	326,554 L.L
G04BD12	BETMIGA	B	Mirabegron - 50mg	50mg	Tablet, prolonged release	3,758,727 L.L
A07EA06	CORTIMENT MMX	B	Budesonide - 9mg	9mg	Tablet, prolonged release	8,996,996 L.L
N05CH01	MELATONINE ARROW LP	G	Melatonin - 2mg	2mg	Tablet, prolonged release	1,716,087 L.L
A08AA62	CONTRAVE	B	Naltrexone Hydrochloride - 8mg, Bupropion Hydrochloride - 90mg		Tablet, prolonged release	11,653,550 L.L

...

181

...